GP 127
Pill imprint GP 127 has been identified as Metformin hydrochloride 850 mg.
Metformin is used in the treatment of diabetes, type 2; insulin resistance syndrome; female infertility; polycystic ovary syndrome and belongs to the drug class non-sulfonylureas. There is no proven risk in humans during pregnancy.
Metformin 850 mg is not subject to the Controlled Substances Act.
See also related documents.
Metformin hydrochloride Images
- Imprint:
-
GP 127
- Strength:
- 850 mg
- Color:
- White
- Size:
- 13.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide colloidal
hypromellose
magnesium stearate
polyethylene glycol
polysorbate 80
povidone
sodium starch glycolate type A potato
corn starch
titanium dioxide
- Drug Class:
- Non-sulfonylureas
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Sandoz Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00781-5051
| NDC Code | Manufacturer / Repackager |
|---|---|
| 00904-5850 | Major Pharmaceuticals |
| 67544-1383 | Prepak Systems Inc (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Metformin Hydrochloride resources
- Metformin
- Metformin (Wolters Kluwer)
- Metformin Extended-Release Tablets (Wolters Kluwer)
- Metformin Solution (Wolters Kluwer)
- metformin (Cerner Multum)
- metformin (Micromedex) - Includes Dosage Information
- Metformin Hydrochloride (AHFS DI)
- Metformin (FDA)
- Metformin Extended Release (FDA)
- Metformin Hydrochloride (Wolters Kluwer)
Search Again
